Αποτελέσματα Αναζήτησης
ADNI is a study that collects and shares data and samples for Alzheimer's disease research. Learn how to access data, join as a participant, or see the impact of ADNI on ADRD research.
- About
About ADNI. The ADNI study actively supports the...
- News & Publications
The Alzheimer’s Disease Neuroimaging Initiative (ADNI) is a...
- HELP / FAQ
The Alzheimer’s Disease Neuroimaging Initiative (ADNI) is a...
- Data and Samples
Data and Samples. Data, including clinical, biofluid,...
- About
13 Αυγ 2024 · ADNI is a multisite, longitudinal, prospective, naturalistic study of normal cognitive aging, mild cognitive impairment (MCI), and early Alzheimer's disease. It aims to develop a public domain research resource to facilitate the scientific evaluation of neuroimaging and other biomarkers for the onset and progression of MCI and Alzheimer's disease.
ADNI is a long-term study that collects data and biospecimens to track the progression of Alzheimer's disease across different stages. Learn about the history, goals, phases, data, samples, and impact of ADNI on AD research worldwide.
Data and Samples. Data, including clinical, biofluid, genetic, imaging, and neuropathology results from ADNI participants, are shared with approved researchers through the LONI Image and Data Archive (IDA), a secure research data repository.
ADNI is a collaborative project that aims to improve clinical trials for the prevention and treatment of AD by using neuroimaging, biochemical, and genetic markers. It enrolls participants with AD, MCI, and healthy controls, and shares data and samples with researchers worldwide.
31 Δεκ 2021 · The Worldwide Alzheimer's Disease Neuroimaging Initiative (WW-ADNI) is a collaborative effort to investigate imaging and biofluid markers that can inform Alzheimer's disease treatment trials. It is a...
31 Δεκ 2021 · The Worldwide Alzheimer's Disease Neuroimaging Initiative (WW-ADNI) is a collaborative effort to investigate imaging and biofluid markers that can inform Alzheimer's disease treatment trials. It is a public-private partnership that spans North America, Argentina, Australia, Canada, China, Japan, Kor ….